A Complete Account of FDA Approvals in 2024

Shots: In 2024, around 50 new drugs were approved by the US FDA across several indications PharmaShots, in an enlightening report, brings a summarized analysis of the approved drugs. The most explored section remains Oncology, Hematology, Dermatology, and Cardiology For the complete report with analysis, reach out to us at connect@pharmashots.com While you embraced the new…

ByDipanshu DixitFebruary 5, 2025

INSIGHTS+

The US FDA New Drug Approvals in October 2024

Shots: PharmaShots has compiled a list of US FDA-approved drugs in the month of October 2024 The US FDA has approved a total of 4 new drugs including 2 new molecular entities and 2 biologics leading to the treatment of patients and advances in the healthcare industry The major highlighted drugs were Pfizer’s Hympavzi for…

ByDipanshu DixitNovember 12, 2024

INSIGHTS+

Insights+: The US FDA New Drug Approvals in July 2024

Shots: PharmaShots has compiled a list of US FDA-approved drugs in the month of July 2024 The US FDA approved a total of 2 new drugs including 1 new molecular entity and 1 biologic leading to the treatments for patients and advances in the healthcare industry The major highlighted drug was Eli Lilly’s Kisunla for…

ByDipanshu DixitAugust 13, 2024

INSIGHTS+

Insights+: The US FDA New Drug Approvals in June 2024

Shots: PharmaShots has compiled a list of US FDA-approved drugs in the month of June 2024 The US FDA approved a total of 5 new drugs including 4 new molecular entities and 1 biologic leading to the treatments for patients and advances in the healthcare industry The major highlighted drug was Ipsen’s Iqirvo for the treatment…

ByDipanshu DixitJuly 16, 2024

INSIGHTS+

Insights+: The US FDA New Drug Approvals in May 2024

Shots: PharmaShots has compiled a list of US FDA-approved drugs in the month of May 2024 The US FDA approved a total of 3 new drugs including 2 new molecular entities and 1 biologic leading to treatments for patients and advances in the healthcare industry The major highlighted drug was Amgen’s Imdelltra for the treatment…

ByDipanshu DixitJune 18, 2024

INSIGHTS+

Insights+: The US FDA New Drug Approvals in April 2024

Shots: PharmaShots has compiled a list of US FDA-approved drugs in the month of April 2024 The US FDA approved a total of 12 new drugs including 11 new molecular entities and 1 biologic leading to the treatments for patients and advances in the healthcare industry The major highlighted drug was X4 Pharmaceuticals’ Xolremdi for…

ByDipanshu DixitMay 14, 2024

INSIGHTS+

Insights+: EMA Marketing Authorization of New Drugs in February 2023

Shots: The EMA approved 7 New Chemical Entity (NCE) and 5 Biologic Drugs in February 2023, leading to treatments for patients and advances in the healthcare industry In February 2023, the major highlights drugs were Forxiga’s Approval for symptomatic chronic heart failure, Fintepla for adjunctive treatment of seizures associated with lennox-gastaut syndrome PharmaShots has compiled…

BySenior EditorMarch 23, 2023

A Complete Account of FDA Approvals in 2024

The US FDA New Drug Approvals in October 2024

Insights+: The US FDA New Drug Approvals in July 2024

Insights+: The US FDA New Drug Approvals in June 2024

Insights+: The US FDA New Drug Approvals in May 2024

Insights+: The US FDA New Drug Approvals in April 2024

Insights+: EMA Marketing Authorization of New Drugs in February 2023

Contact US

OUR INFORMATION

FOLLW US

A Complete Account of FDA Approvals in 2024

The US FDA New Drug Approvals in October 2024

Insights+: The US FDA New Drug Approvals in July 2024

Insights+: The US FDA New Drug Approvals in June 2024

Insights+: The US FDA New Drug Approvals in May 2024

Insights+: The US FDA New Drug Approvals in April 2024

Insights+: EMA Marketing Authorization of New Drugs in February 2023

FOLLW US

Sign Up to Our Newsletter